anonymous
Guest
anonymous
Guest
Is there a bad middle management idea that Merck isn’t willing to adopt? Can someone please tell me the new meddling fad in advance of the barrage of pointless questions and interrogations about my business before it happens!? It’s as though they’re trying ever harder to justify their role as keytruda passes 15B annually.